Page last updated: 2024-08-25

cholest-5-ene-3,4-diol and Behavior Disorders

cholest-5-ene-3,4-diol has been researched along with Behavior Disorders in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Andreassen, OA; Gjestad, C; Haslemo, T; Molden, E	1

Other Studies

1 other study(ies) available for cholest-5-ene-3,4-diol and Behavior Disorders

Article	Year
4β-Hydroxycholesterol level significantly correlates with steady-state serum concentration of the CYP3A4 substrate quetiapine in psychiatric patients. British journal of clinical pharmacology, 2017, Volume: 83, Issue:11 Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antipsychotic Agents; Biomarkers, Pharmacological; Cytochrome P-450 CYP3A; Delayed-Action Preparations; Female; Humans; Hydroxycholesterols; Male; Mental Disorders; Middle Aged; Prospective Studies; Quetiapine Fumarate; Sex Factors; Tablets; Young Adult	2017

Article

Year

4β-Hydroxycholesterol level significantly correlates with steady-state serum concentration of the CYP3A4 substrate quetiapine in psychiatric patients.

British journal of clinical pharmacology, 2017, Volume: 83, Issue:11

Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antipsychotic Agents; Biomarkers, Pharmacological; Cytochrome P-450 CYP3A; Delayed-Action Preparations; Female; Humans; Hydroxycholesterols; Male; Mental Disorders; Middle Aged; Prospective Studies; Quetiapine Fumarate; Sex Factors; Tablets; Young Adult

2017